Aptiom
NDC 63402-204, ESLICARBAZEPINE ACETATE, tablet, from Sumitomo Pharma America, Inc..
- Product NDC
- 63402-204
- Status
- Listed
- Labeler
- Sumitomo Pharma America, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022416
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63402-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ESLICARBAZEPINE ACETATE400 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63402-204-28 | 63402020428 | 4 BLISTER PACK in 1 CARTON (63402-204-28) / 7 TABLET in 1 BLISTER PACK (63402-204-07) |
| 63402-204-30 | 63402020430 | 30 TABLET in 1 BOTTLE (63402-204-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/3d0c9554-eaeb-4694-8089-00133fcadce3NADAC price for package 63402020430
GET /v1/drugs/nadac/63402020430
Use it
Look up 63402-204 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63402-204 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63402-204. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.